In addition, flow cytometric analysis showed increased infiltration of CD8+ T cells into the tumor microenvironment after treatment with either the MUC1 mRNA vaccine or CTLA-4 siRNA-loaded NLE, with the combination therapy showing the strongest effect. Here, MUC1 is linked to neoplasm.